✦ LIBER ✦

The number of resected axillary lymph nodes (ALN) influences the risk for axillary recurrences in node-positive, but not in node-negative patients

✍ Scribed by W Janni; B Gerber; B Rack; B Strobl; W Thieleke; H Sommer; K Friese

Book ID: 118622044
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 174 KB
Volume: 2
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(04)90696-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The number of resected axillary lymph no

The number of resected axillary lymph nodes (ALN) influences the risk for axillary recurrences in node-positive, but not in node-negative patients

✍ W Thieleke; W Janni; B Rack; B Strobl; D Riosk; H Sommer; B Gerber; K Friese 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 349 KB

331 POSTER The number of recovered axill

331 POSTER The number of recovered axillary lymph nodes affects lymph node recurrence but not specific survival in node-negative breast cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

The prognostic significance of total lym

The prognostic significance of total lymph node number in patients with axillary lymph node-negative breast cancer

✍ H Mersin; E Yıldırım; H Bulut; U Berberoğlu 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 95 KB

When is a Lymph Node Dissection a Lymph

When is a Lymph Node Dissection a Lymph Node Dissection? The Number of Lymph Nodes Resected in Sentinel and Axillary Lymph Node Dissections

✍ Windy Olaya MD,Jasmine Wong MD,Jan Wong MD… 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 189 KB

The Need for Axillary Dissection in Pati

The Need for Axillary Dissection in Patients with Positive Axillary Sentinel Lymph Nodes

✍ Randal L. Croshaw; Kathleen M. Erb; Hilary M. Shapiro-Wright; Thomas B. Julian 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 127 KB

The prognostic significance of the perce

The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes

✍ Pauline T. Truong; Eric Berthelet; Junella Lee; Hosam A. Kader; Ivo A. Olivotto 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB 👁 2 views

## Abstract ## BACKGROUND Adjuvant therapy for women with T1–T2 breast carcinoma and 1–3 positive lymph nodes is controversial due to discrepancies in reported baseline locoregional recurrence (LRR) risks. This inconsistency has been attributed to variations in lymph node staging techniques, which